超声初评为可能良性或低度可疑的乳腺癌其内在亚型随肿瘤大小而异
研究纳入444例超声引导下空心针活检初评为BI-RADS 3或4a类的乳腺癌,按肿瘤≤10 mm或>10 mm分组分析内在亚型。≤10 mm组luminal型占74.9%(185/247),高于>10 mm组的56.9%(112/197)(P<.001);三阴性型在>10 mm组占24.9%(49/197),高于≤10 mm组的14.2%(35/247)(P=.012);HER2型两组无显著差异(P=.084)。
要点
- 超声初评BI-RADS 3或4a类的乳腺癌中,≤10 mm者以luminal型更常见(74.9% vs 56.9%,P<.001)。
- >10 mm者三阴性型更常见(24.9% vs 14.2%,P=.012)。
- HER2型在≤10 mm与>10 mm组间无显著差异(10.9% vs 18.3%,P=.084)。
核心结论
- 超声初评为BI-RADS 3或4a类的乳腺癌,其内在亚型随肿瘤大小不同:luminal型在≤10 mm肿瘤中更常见,三阴性型在>10 mm肿瘤中更常见。
研究设计与样本
- 研究共纳入439例患者的444个乳腺癌,均经超声引导下空心针活检初评为BI-RADS 3或4a类;按肿瘤≤10 mm或>10 mm分组,分为luminal型、HER2型、三阴性型并分析其与肿瘤大小的关系。
诊断标准与关键数值
- 以10 mm为界将肿瘤分为≤10 mm组(247个,55.6%)和>10 mm组(197个,44.4%)。
- luminal型定义为ER阳性和/或PR阳性且HER2阴性,≤10 mm组185/247(74.9%)vs >10 mm组112/197(56.9%),P<.001。
- HER2型定义为HER2阳性(不论ER或PR状态),≤10 mm组27/247(10.9%)vs >10 mm组36/197(18.3%),P=.084。
- 三阴性型定义为ER阴性、PR阴性且HER2阴性,>10 mm组49/197(24.9%)vs ≤10 mm组35/247(14.2%),P=.012。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate whether the intrinsic subtypes of breast cancers initially assessed as American College of Radiology Breast Imaging and Reporting System (BI-RADS) category 3 or 4a differ according to tumor size.
METHODS: A total of 444 breast cancers in 439 patients initially assessed as BI-RADS 3 or 4a through ultrasound-guided core needle biopsy were included. Tumors were classified by the size criterion of 10 mm or smaller or larger than 10 mm and categorized as the luminal type (estrogen receptor [ER] positive and/or progesterone receptor [PR] positive and human epidermal growth factor receptor 2 [HER2] negative), HER2 type (HER2 positive regardless of ER or PR status), or triple-negative type (ER negative, PR negative, and HER2 negative). The relationships between tumor size and breast cancer intrinsic subtypes were analyzed.
RESULTS: A total of 247 (55.6%) cancers were 10 mm or smaller, and 197 (44.4%) were larger than 10 mm. The luminal type was more frequently present in tumors of 10 mm or smaller (185 of 247 [74.9%]) than those larger than 10 mm (112 of 197 [56.9%]; P < .001). No significant difference was noted in the frequency of the HER2 type in tumors of 10 and mm smaller and those larger than 10 mm (27 of 247 [10.9%] versus 36 of 197 [18.3%]; P = .084). The triple-negative type was more frequently present in tumors larger than 10 mm than those of 10 mm or smaller (49 of /197 [24.9%] versus 35 of 247 [14.2%]; P = .012).
CONCLUSIONS: Breast cancers assessed as BI-RADS category 3 or 4a had differing intrinsic subtypes according to tumor size, as the luminal type was more frequently present in tumors of 10 mm or smaller than those larger than 10 mm, whereas the triple-negative type was more frequently present in tumors larger than 10 mm.
引用
- Koh J, Kim MJ, Moon HJ, et al. Intrinsic Subtypes of Breast Cancers Initially Assessed as Probably Benign or of Low Suspicion on Ultrasonography Differ According to Tumor Size. J Ultrasound Med. 2017. PMID: 29148091. doi:10.1002/jum.14495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。